Expect Questions About Trelegy for Asthma
The "three-in-one" Trelegy Ellipta inhaler is now approved for ASTHMA...not just for COPD.
Trelegy contains the inhaled corticosteroid (ICS) fluticasone furoate...the long-acting beta-agonist (LABA) vilanterol...and the long-acting muscarinic antagonist (LAMA) umeclidinium.
Trelegy seems to improve lung function in asthma patients not controlled on a medium- or high-dose ICS/LABA...but isn't yet shown to reduce exacerbations.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote